Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph N Contessa

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|December 16, 2024
OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-GlycosylationMarta Baro, Hojin Lee, Vanessa Kelley, et al.
JAMA Oncology|January 6, 2017
Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational StudyJacqueline R Kelly, Henry S Park, Yi An, et al.
Neoplasia (New York, N.Y.)|January 10, 2014
Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domainJ Ryan Petrulli, Jenna M Sullivan, Ming-Qiang Zheng, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
A contemporary dose selection algorithm for stereotactic radiosurgery in the treatment of brain metastases - An initial reportRovel J Colaco, James B Yu, James S Bond, et al.
Frontiers in Oncology|April 20, 2018
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell CarcinomaWilliam S Chen, Ranjit S Bindra, Allen Mo, et al.
Cancer Letters|November 15, 2021
Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinomaJ Nicholas Fisk, Amandeep R Mahal, Alex Dornburg, et al.
Cancer Research|January 27, 2026
Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to KIF18A InhibitionVanessa M Kelley, Marta Baro, William E Gasperi, et al.
Oral Oncology|March 31, 2018
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancerJacqueline R Kelly, Henry S Park, Yi An, et al.
Cancer Research|July 21, 2018
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsCecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, et al.
Molecular Cell|December 5, 2023
ER chaperones use a protein folding and quality control glyco-codeKevin P Guay, Haiping Ke, Nathan P Canniff, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|December 16, 2024
OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-GlycosylationMarta Baro, Hojin Lee, Vanessa Kelley, et al.
JAMA Oncology|January 6, 2017
Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational StudyJacqueline R Kelly, Henry S Park, Yi An, et al.
Neoplasia (New York, N.Y.)|January 10, 2014
Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domainJ Ryan Petrulli, Jenna M Sullivan, Ming-Qiang Zheng, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
A contemporary dose selection algorithm for stereotactic radiosurgery in the treatment of brain metastases - An initial reportRovel J Colaco, James B Yu, James S Bond, et al.
Frontiers in Oncology|April 20, 2018
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell CarcinomaWilliam S Chen, Ranjit S Bindra, Allen Mo, et al.
Cancer Letters|November 15, 2021
Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinomaJ Nicholas Fisk, Amandeep R Mahal, Alex Dornburg, et al.
Cancer Research|January 27, 2026
Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to KIF18A InhibitionVanessa M Kelley, Marta Baro, William E Gasperi, et al.
Oral Oncology|March 31, 2018
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancerJacqueline R Kelly, Henry S Park, Yi An, et al.
Cancer Research|July 21, 2018
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsCecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, et al.
Molecular Cell|December 5, 2023
ER chaperones use a protein folding and quality control glyco-codeKevin P Guay, Haiping Ke, Nathan P Canniff, et al.
Pageof 7